A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of CC-99677 in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 23, 2018

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions

Healthy Volunteer

Interventions

DRUG

CC-99677

OTHER

Placebo

Trial Locations (1)

Quotient Clinical, Ruddington